好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Detailed Analysis of CD52 Expression and Cellular Depletion/Repopulation after Alemtuzumab Treatment in HuCD52 Transgenic Mice
MS and Related Diseases
(-)
207
Authors/Disclosures
Michael J. Turner, PhD (Sanofi Genzyme) No disclosure on file
Mary Carter Denny, MD (MedStar Georgetown University Hospital) Dr. Denny has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Laboratory. The institution of Dr. Denny has received research support from NIDDILIR. Dr. Denny has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
No disclosure on file
Johanne M. Kaplan, PhD (ProMIS Neurosciences) Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Bruce Roberts, PhD No disclosure on file
William M. Siders, PhD No disclosure on file